NCT06361680
Effect of Coenzyme Q10 on Diabetic Children
Efficacy of Coenzyme Q10 Supplementation on Metabolic Control in Children With Type 1 Diabetes Mellitus: a Randomized Clinical Trial
Assiut University·Phase 1·ClinicalTrials.gov·drugNot yet recruiting
View on ClinicalTrials.gov →Study focus
- Disease/Condition
- Type 1 Diabetes Mellitus
- Drug/Device/Intervention
- Coenzyme Q10 Cap/Tab as natural factors capsules or kirkman tablets
- Study type
- Interventional
- Intervention type
- drug
Sponsor & location
- Primary sponsor
- Assiut University
Timeline & enrollment
- Phase
- Phase 1
- Start date
- Oct 30, 2024
- End date
- Nov 30, 2025
- Enrollment
- 100 participants
Primary outcome
Assess the effect of Coenzyme Q10 on glycated haemoglobin in type 1 diabetes mellitus
Summary
Determine the effect of Coenzyme Q10 on random blood sugar and glycosylated haemoglobin
ICD-10 classifications
Type 1 diabetes mellitusType 1 diabetes mellitus with unspecified complicationsType 1 diabetes mellitus with other specified complicationsType 1 diabetes mellitus without complicationsType 1 diabetes mellitus with multiple complications
Data source
- Registry
- ClinicalTrials.gov
- Trial ID
- NCT06361680
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for NCT06361680 through Pure Global AI's free database. This Phase 1 trial is sponsored by Assiut University and is currently Not yet recruiting. The study focuses on Type 1 Diabetes Mellitus. Target enrollment is 100 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.